InfraScan, Inc.
InfraScan, Inc. is a medical device company dedicated to developing, commercializing, and distributing portable brain scanners for head injury and stroke assessment using Near-Infrared (NIR) technology. The Infrascanner allows clinicians to effectively and accurately detect intracranial bleeding in patients with head trauma, significantly improving patient outcomes and reducing brain tissue damage.
Industries
Nr. of Employees
small (1-50)
InfraScan, Inc.
1384 Karen Ln, Radnor, PA 19087
Awards
Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)
SAFETY: Stabilization points to third hospital line Assessment oF Effectiveness of Infrascanner Model 2500 for diagnostic/screening of Traumatic Brain InjurY in Ukraine
Funding (ceiling)
$3,650,127.76
Award Year
2024
Patents
Products
Handheld near-infrared intracranial hematoma screening device
A lightweight, handheld optical device that performs rapid bedside screening for traumatic supratentorial hematomas using near-infrared spectroscopy and provides an immediate graphic positive/negative result to inform triage.
Handheld near-infrared intracranial hematoma screening device
A lightweight, handheld optical device that performs rapid bedside screening for traumatic supratentorial hematomas using near-infrared spectroscopy and provides an immediate graphic positive/negative result to inform triage.
Expertise Areas
- Traumatic brain injury (TBI) screening and triage
- Prehospital and military field diagnostics
- Near-infrared spectroscopy device development
- Clinical validation and multi-center effectiveness studies
Key Technologies
- Near-infrared spectroscopy (NIRS)
- Eye-safe diode laser optics
- Optical detectors and disposable light guides
- Embedded signal processing (single-board computer)
Key People
Investors
Seed Round - InfraScan
Announced on 2014-03-24.
Seed Round - InfraScan
Announced on 2008-11-18.
BioAdvance
$500,000 funded.
Announced on 2005-10-05.
Seed Round - InfraScan
Announced on 2005-03-16.
Seed Round - InfraScan
Announced on 2014-03-24.
Seed Round - InfraScan
Announced on 2008-11-18.
BioAdvance
$500,000 funded.
Announced on 2005-10-05.
Seed Round - InfraScan
Announced on 2005-03-16.
News & Updates
InfraScan Inc. has been recognized for its impact on patient care in the life sciences sector.
A significant study has been published demonstrating the effectiveness of the Infrascanner in diagnosing traumatic brain injuries.
InfraScan Inc. has been recognized for its impact on patient care in the life sciences sector.
A significant study has been published demonstrating the effectiveness of the Infrascanner in diagnosing traumatic brain injuries.